[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Wednesday (August 14) reported over two-fold increase in consolidated net profit to ₹340.2 crore for the first quarter that ended June 30, 2024. In the corresponding quarter, Glenmark Pharmaceuticals posted a net profit of ₹37.7 crore, the company said in a regulatory filing. The company reported consolidated profit […]